--- title: "Michael Klein's SPAC Churchill Capital XII prices upsized $360 million IPO" type: "News" locale: "en" url: "https://longbridge.com/en/news/284377390.md" description: "Churchill Capital XII, a SPAC founded by Michael Klein, has raised $360 million through an IPO by offering 36 million units at $10 each. Each unit includes one share of common stock and a warrant. The SPAC aims to target businesses with recurring revenue and strong management teams. Klein's previous SPACs include Churchill Capital XI and X, with various outcomes. The company will trade on Nasdaq under the symbol CXIIU, with Citi as the sole bookrunner." datetime: "2026-04-28T11:44:00.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/284377390.md) - [en](https://longbridge.com/en/news/284377390.md) - [zh-HK](https://longbridge.com/zh-HK/news/284377390.md) --- # Michael Klein's SPAC Churchill Capital XII prices upsized $360 million IPO Churchill Capital XII, a blank check company founded by dealmaker and former Citi executive Michael Klein, raised $360 million by offering 36 million units at $10. Each unit consists of one share of common stock, and one-tenth of one warrant to purchase a share, exercisable at $11.50. The company is led by **CEO and Chairman Michael Klein**, the founder and Managing Partner of strategic advisory firm M. Klein and Company. He previously held various roles at Citi and Salomon Smith Barney. He is joined by **CFO Jay Taragin**, the CFO of M. Klein and Company. The SPAC plans to target businesses that have recurring revenue, potential to generate stable free cash flow, potential to grow through additional acquisitions, are sourced through Churchill's proprietary channels, and have a committed and capable management team, among other characteristics. Klein's most recent SPACs include **Churchill Capital XI** (CCXIU; +3% from $10 offer price), which went public in December 2026, Churchill Capital X which is merged with quantum computer developer **Infleqtion** (INFQ; +33%), **Churchill Capital Corp IX** (CCIX; +8%), which is pending a merger with autonomous trucking software developer PlusAI, and **Churchill Capital Corp VII** (CVII), **Churchill Capital VI** (CCVI.U), and **Churchill Capital V** (CCV.U) which have all liquidated. Other past SPACs include Churchill Capital Corp IV, which merged with EV maker **Lucid** (LCID; -41%) in 2021, and Churchill Capital Corp III, which merged with healthcare services provider **MultiPlan** (now Claritev; CTEV; +75%) in 2020. The New York, NY-based company will trade on the Nasdaq under the symbol CXIIU. Citi acted as sole bookrunner on the deal. ### Related Stocks - [CCCX.US](https://longbridge.com/en/quote/CCCX.US.md) - [CCXIU.US](https://longbridge.com/en/quote/CCXIU.US.md) - [CCCXW.US](https://longbridge.com/en/quote/CCCXW.US.md) - [C.US](https://longbridge.com/en/quote/C.US.md) - [INFQ.US](https://longbridge.com/en/quote/INFQ.US.md) - [CCIX.US](https://longbridge.com/en/quote/CCIX.US.md) - [LCID.US](https://longbridge.com/en/quote/LCID.US.md) - [CTEV.US](https://longbridge.com/en/quote/CTEV.US.md) - [CCCXU.US](https://longbridge.com/en/quote/CCCXU.US.md) - [INFQ.WS.US](https://longbridge.com/en/quote/INFQ.WS.US.md) - [C-R.US](https://longbridge.com/en/quote/C-R.US.md) - [INFQ+.US](https://longbridge.com/en/quote/INFQ+.US.md) - [MPLNW.US](https://longbridge.com/en/quote/MPLNW.US.md) ## Related News & Research - [Michael Klein's latest SPAC Churchill Capital Corp XIII prices upsized $360 million IPO](https://longbridge.com/en/news/294516663.md) - [SPAC B&R Technology Merger prices $325 million IPO, targeting tech with AI tailwinds](https://longbridge.com/en/news/293343219.md) - [Keen Vision Acquisition faces Nasdaq delisting over SPAC deadline breach, float shortfall](https://longbridge.com/en/news/294417990.md) - [SPAC Karman Line Acquisition files for a $200 million IPO, targeting aerospace and defense](https://longbridge.com/en/news/293933864.md) - [Baird Medical Investment Holdings files Form 3 beneficial ownership statement by ExcelFin SPAC LLC](https://longbridge.com/en/news/294555481.md)